Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O G Chelnokova

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Terapevticheskii Arkhiv|April 30, 2003
[Errors in diagnosing pulmonary tuberculosis in general hospitals and results of treating the disease]O G Chelnokova, B S Kibrik
Problemy Tuberkuleza I Boleznei Legkikh|February 22, 2005
[Problems of the epidemiology, diagnosis, and treatment of caseous pneumonia]B S Kibrik, O G Chelnokova
Problemy Tuberkuleza I Boleznei Legkikh|December 18, 2007
[Extracorporeal antiaggregant pharmacotherapy in the treatment of acutely progressive forms of tuberculosis]B S Kibrik, O G Chelnokova
Problemy Tuberkuleza I Boleznei Legkikh|July 21, 2006
[Diagnostic features for the early variant of caseous pneumonia]B S Kibrik, O G Chelnokova
Problemy Tuberkuleza I Boleznei Legkikh|November 6, 2003
[Use of isofon in combined treatment of patients with acutely progressive forms of tuberculosis]O G Chelnokova, B S Kibrik
Problemy Tuberkuleza I Boleznei Legkikh|March 11, 2008
[Diagnostic and treatment policy errors in caseous pneumonia]B S Kibrik, O G Chelnokova
Problemy Tuberkuleza I Boleznei Legkikh|September 24, 2004
[Pathogenetic therapy for caseous pneumonia]O G Chelnokova, B S Kibrik
Problemy Tuberkuleza I Boleznei Legkikh|August 6, 2003
[Extracorporeal immunopharmacological therapy in the treatment of patients with acutely progressing froms of pulmonary tuberculosis]O G Chelnokova, B S Kibrik
Problemy Tuberkuleza I Boleznei Legkikh|October 4, 2003
[Some specific features of drug resistance of Mycobacteria tuberculosis in patients with acutely progressive destructive forms of pulmonary tuberculosis]B S Kibrik, O G Chelnokova
Eksperimental'Naia I Klinicheskaia Farmakologiia|May 2, 2013
[Bacteriological substantiation of the antituberculosis effect of immunotropic drug tubosan]B S Kibrik, A V Pavlov, O G Chelnokova
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Terapevticheskii Arkhiv|April 30, 2003
[Errors in diagnosing pulmonary tuberculosis in general hospitals and results of treating the disease]O G Chelnokova, B S Kibrik
Problemy Tuberkuleza I Boleznei Legkikh|February 22, 2005
[Problems of the epidemiology, diagnosis, and treatment of caseous pneumonia]B S Kibrik, O G Chelnokova
Problemy Tuberkuleza I Boleznei Legkikh|December 18, 2007
[Extracorporeal antiaggregant pharmacotherapy in the treatment of acutely progressive forms of tuberculosis]B S Kibrik, O G Chelnokova
Problemy Tuberkuleza I Boleznei Legkikh|July 21, 2006
[Diagnostic features for the early variant of caseous pneumonia]B S Kibrik, O G Chelnokova
Problemy Tuberkuleza I Boleznei Legkikh|November 6, 2003
[Use of isofon in combined treatment of patients with acutely progressive forms of tuberculosis]O G Chelnokova, B S Kibrik
Problemy Tuberkuleza I Boleznei Legkikh|March 11, 2008
[Diagnostic and treatment policy errors in caseous pneumonia]B S Kibrik, O G Chelnokova
Problemy Tuberkuleza I Boleznei Legkikh|September 24, 2004
[Pathogenetic therapy for caseous pneumonia]O G Chelnokova, B S Kibrik
Problemy Tuberkuleza I Boleznei Legkikh|August 6, 2003
[Extracorporeal immunopharmacological therapy in the treatment of patients with acutely progressing froms of pulmonary tuberculosis]O G Chelnokova, B S Kibrik
Problemy Tuberkuleza I Boleznei Legkikh|October 4, 2003
[Some specific features of drug resistance of Mycobacteria tuberculosis in patients with acutely progressive destructive forms of pulmonary tuberculosis]B S Kibrik, O G Chelnokova
Eksperimental'Naia I Klinicheskaia Farmakologiia|May 2, 2013
[Bacteriological substantiation of the antituberculosis effect of immunotropic drug tubosan]B S Kibrik, A V Pavlov, O G Chelnokova
Pageof 2